|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
6:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Parkin DM: Global cancer statistics in the
year 2000. Lancet Oncol. 2:533–543. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Poortmans P, Marsiglia H, Heras MDL and
Algara M: Clinical and technological transition in breast cancer.
Rep Pract Oncol Radiother. 18:345–352. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rivenbark AG, O'Connor SM and Coleman WB:
Molecular and cellular heterogeneity in breast cancer: Challenges
for personalized medicine. Am J Pathol. 183:1113–1124. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bartel D: MicroRNAs: Genomics, biogenesis,
mechanism, and function. Cell. 116:281–297. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Iorio MV and Croce CM: MicroRNAs in
cancer: Small molecules with a huge impact. J Clin Oncol.
27:5848–5856. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liang L, Fu J, Wang S, Cen H, Zhang L,
Mandukhail SR, Du L, Wu Q, Zhang P and Yu X: MiR-142-3p enhances
chemosensitivity of breast cancer cells and inhibits autophagy by
targeting HMGB1. Acta Pharm Sin B. 10:1036–1046. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Greene SB, Herschkowitz JI and Rosen JM:
The ups and downs of miR-205: Identifying the roles of miR-205 in
mammary gland development and breast cancer. RNA Biol. 7:300–304.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Al-Nakhle H, Burns PA, Cummings M, Hanby
AM, Hughes TA, Satheesha S, Shaaban AM, Smith L and Speirs V:
Estrogen receptor {beta}1 expression is regulated by miR-92 in
breast cancer. Cancer Res. 70:4778–4784. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lu Y and Tang S: miR-217 targeted to MAPK1
for the inhibition of metastasis and invasion of gastric cancer
cell. Mod Med J Chin. 11:21–23. 2014.(In Chinese).
|
|
11
|
Zhao WG, Yu SN, Lu ZH, Ma YH and Chen J:
The miR-217 microRNA functions as a potential tumor suppressor in
pancreatic ductal adenocarcinoma by targeting KRAS. Carcinogenesis.
31:1726–1733. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wei R, Deng Z and Su J: miR-217 targeting
Wnt5a in osteosarcoma functions as a potential tumor suppressor.
Biomed Pharmacother. 72:158–164. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pastushenko I and Blanpain C: EMT
transition states during tumor progression and metastasis. Trends
Cell Biol. 29:212–226. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Savary K, Termén S, Thuault S, Keshamouni
V and Moustakas A: Epithelial-mesenchymal transition as a mechanism
of metastasis. Lung Cancer Metastasis. Keshamouni V, Arenberg D and
Kalemkerian G: 1st edition. Springer; New York, NY: pp. 65–92.
2010
|
|
15
|
Abe-Yutori M, Chikazawa T, Shibasaki K and
Murakami S: Decreased expression of E-cadherin by porphyromonas
gingivalis-lipopolysaccharide attenuates epithelial barrier
function. J Periodontal Res. 52:42–50. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Su ZZ, Kang DC, Chen Y, Pekarskaya O, Chao
W, Volsky DJ and Fisher PB: Identification and cloning of human
astrocyte genes displaying elevated expression after infection with
HIV-1 or exposure to HIV-1 envelope glycoprotein by rapid
subtraction hybridization, RaSH. Oncogene. 21:3592–3602. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jin H, Shi X, Zhao Y, Peng M, Kong Y, Qin
D and Lv X: MicroRNA-30a mediates cell migration and invasion by
targeting metadherin in colorectal cancer. Technol Cancer Res
Treat. 17:1533033818758102018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Guo J, Xia B, Meng F and Lou G: MiR-137
suppresses cell growth in ovarian cancer by targeting AEG-1.
Biochem Biophys Res Commun. 441:357–363. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gnosa S, Ticha I, Haapaniemi S and Sun XF:
MTDH genetic variants in colorectal cancer patients. Sci Rep.
6:231632016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gnosa S, Shen YM, Wang CJ, Zhang H,
Stratmann J, Arbman G and Sun XF: Expression of AEG-1 mRNA and
protein in colorectal cancer patients and colon cancer cell lines.
J Transl Med. 10:1092012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhu Y, Zhao H, Li F and Xu S: MicroRNA-217
inhibits cell proliferation and invasion by targeting Runx2 in
human glioma. Am J Transl Res. 8:1482–1491. 2016.PubMed/NCBI
|
|
22
|
Menghini R, Casagrande V, Cardellini M,
Martelli E, Terrinoni A, Amati F, Vasa-Nicotera M, Ippoliti A,
Novelli G, Melino G, et al: MicroRNA 217 modulates endothelial cell
senescence via silent information regulator 1. Circulation.
120:1524–1532. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li H, Zhao J, Zhang JW, Huang QY, Huang
JZ, Chi LS, Tang HJ, Liu GQ, Zhu DJ and Ma WM: MicroRNA-217,
down-regulated in clear cell renal cell carcinoma and associated
with lower survival, suppresses cell proliferation and migration.
Neoplasma. 60:511–515. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen DL, Zhang DS, Lu YX, Chen LZ, Zeng
ZL, He MM, Wang FH, Li YH, ZhangH Z, Pelicano H, et al:
MicroRNA-217 inhibits tumor progression and metastasis by
downregulating EZH2 and predicts favorable prognosis in gastric
cancer. Oncotarget. 6:10868–10879. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang S, Liu X, Liu J, Guo H, Xu H and
Zhang G: PGC-1 alpha interacts with microRNA-217 to functionally
regulate breast cancer cell proliferation. Biomed Pharmacother.
85:541–548. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yébenes VG, Bartolomé-Izquierdo N,
Nogales-Cadenas R, Pérez-Durán P, Mur SM, Martínez N, Lisio LD,
Robbiani DF, Pascual-Montano A, Cañamero M, et al: miR-217 is an
oncogene that enhances the germinal center reaction. Blood.
124:229–239. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang Q, Yuan Y, Cui J, Xiao T and Jiang
D: MiR-217 promotes tumor proliferation in breast cancer via
targeting DACH1. J Cancer. 6:184–191. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhou W, Song F, Wu Q, Rong L, Liu R, Wang
L, Liu C, Peng Y, Mao S, Feng J and Chen C: miR-217 inhibits
triple-negative breast cancer cell growth, migration, and invasion
through targeting KLF5. PLoS One. 12:e01763952017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Martello G, Rosato A, Ferrari F, Manfrin
A, Cordenonsi M, Dupont S, Enzo E, Guzzardo V, Rondina M, Spruce T,
et al: A microRNA targeting dicer for metastasis control. Cell.
141:1195–1207. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Su J, Wang Q, Liu Y and Zhong M: miR-217
inhibits invasion of hepatocellular carcinoma cells through direct
suppression of E2F3. Mol Cell Biochem. 392:289–296. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Nishioka C, Ikezoe T, Yang J, Nobumoto A,
Tsuda M and Yokoyama A: Downregulation of miR-217 correlates with
resistance of Ph (+) leukemia cells to ABL tyrosine kinase
inhibitors. Cancer Sci. 105:297–307. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
El-Ashmawy NE, El-Zamarany EA, Khedr EG
and Abo-Saif MA: Activation of EMT in colorectal cancer by
MTDH/NF-κB p65 pathway. Mol Cell Biochem. 457:83–91. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhou J, Hao Z, Gu P, Bai J, Margolick JB
and Zhang Y: NF-kappaB pathway inhibitors preferentially inhibit
breast cancer stem-like cells. Breast Cancer Res Treat.
111:419–427. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ghafouri-Fard S, Abak A, Hussen BM, Taheri
M and Sharifi G: The emerging role of non-coding RNAs in pituitary
gland tumors and meningioma. Cancers (Basel). 13:59872021.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhou CX, Wang CL, Yu AL, Wang QY, Zhan MN,
Tang J, Gong XF, Yin QQ, He M, He JR, et al: MiR-630 suppresses
breast cancer progression by targeting metadherin. Oncotarget.
7:1288–1299. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wan L and Kang K: Pleiotropic roles of
AEG-1/MTDH/LYRIC in breast cancer. Adv Cancer Res. 120:113–134.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Meng X, Thiel KW and Leslie KK: Drug
resistance mediated by AEG-1/MTDH/LYRIC. Adv Cancer Res.
120:135–157. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lu Q, Shan S, Li Y, Zhu D, Jin W and Ren
T: Long noncoding RNA SNHG1 promotes non-small cell lung cancer
progression by up-regulating MTDH via sponging miR-145-5p. FASEB J.
32:3957–3967. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wang B, Shen ZL, Jiang KW, Zhao G, Wang
CY, Yan YC, Yang Y, Zhang JZ, Shen C, Gao ZD, et al: MicroRNA-217
functions as a prognosis predictor and inhibits colorectal cancer
cell proliferation and invasion via an AEG-1 dependent mechanism.
BMC Cancer. 15:4372015. View Article : Google Scholar : PubMed/NCBI
|
